DAWN Partnerships & Advisory Board

DAWN partnerships

In partnership with diabetes associations, healthcare professionals, and governments we advocate to put diabetes on the global agenda and to improve the quality of care for people with diabetes. We work in collaboration with advisory boards of key opinion leaders and research institutions to develop educational tools for health care providers.

The core partners for the global DAWN Programme are the International Diabetes Federation (IDF) and the International Society for Paediatric and Adolescent Diabetes (ISPAD) who have supported the DAWN Programme since its inception and continue to act as strong partners.

A number of key areas of joint strategic interest between IDF, ISPAD, and Novo Nordisk overall in diabetes is supported by the DAWN Initiative. Key elements include:

Facilitate consensus and cross-national collaboration towards implementation of evidence-based patient-centric care strategies
Facilitate implementation of diabetes care guidelines, in regard to the DAWN™ and DAWN Youth Call to Action Priority Areas
Other key partners with agendas relevant for the DAWN™ Programme are the DAWN/DAWN Youth International Advisory Board members, PSAD (Psychosocial Aspects of Diabetes study group), FEND (Federations of European Nurses in Diabetes), AADE (American Association of Diabetes Educators), ESPE (European Society for Paediatric Endocrinology), EU SWEET Programme, Hvidøre Study Group on Childhood Diabetes, IAPO (International Alliance of Patients' Organizations), WHO (World Health Organization), PCDE (Primary Care Diabetes Europe)

DAWN Scientific Advisory board

The DAWN International advisory board plays a pivotal role in reviewing and evaluating the ongoing strategies and activities of the DAWN programme, and publishing scientific results of the study.

The current members of the DAWN scientific advisory panel are:

  • Frank Snoek, Professor, Diabetes Research Group, Department of Medical Psychology, Vrije Universiteit Hospital, Amsterdam. Chairman of PSAD, Psychosocial Aspects of Diabetes study group, EASD (European Association for the Study of Diabetes)
  • Ruth Colagiuri, Vice President, Australian Diabetes Educators Association.
    Director, Australian Centre for Diabetes Strategies, Sydney
  • Dr David Matthews, Professor, Chairman, Oxford Centre for Diabetes, Endocrinology and Metabolism
  • Ib Brorly, person with type 2 diabetes and is vice-chairman of the Danish Diabetes Association
  • Dr Torsten Lauritzen, MD DMSC
    Professor, Family physician, Aarhus University, Denmark
  • Dr Line Kleinebreil, DiabCare France
    Rüdiger Landgraf, MD Medizinische Klinik, Klinikum der Universität München, Germany
  • Dr Hitoshi Ishii, Tenri Yorozu Soudanjyo Hospital, Japan
  • Dr P.H.L.M. Geelhoed - Duijvestijn, Haaglandlanden Hospital, location Westeinde, The Netherlands
  • Dr Richard Rubin, Associated Professor, John Hopkins University School of Medicine. Dept. of Medicine and Pediatrics, US  

Back to top